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This work reports the acceptance testing and commissioning experience of the Robotic Intensity-
Modulated Radiation Therapy (IMRT) M6 system with a newly released InCiseTM2 Multileaf 
Collimator (MLC) installed at the Yonsei Cancer Center. Acceptance testing included a mechanical 
interdigitation test, leaf positional accuracy, leakage check, and End-to-End (E2E) tests. Beam data 
measurements included tissue-phantom ratios (TPRs), off-center ratios (OCRs), output factors 
collected at 11 field sizes (the smallest field size was 7.6 mm×7.7 mm and largest field size was 
115.0 mm×100.1 mm at 800 mm source-to-axis distance), and open beam profiles. The beam 
model was verified by checking patient-specific quality assurance (QA) in four fiducial-inserted 
phantoms, using 10 intracranial and extracranial patient plans. All measurements for acceptance 
testing satisfied manufacturing specifications. Mean leaf position offsets using the Garden Fence 
test were found to be 0.01±0.06 mm and 0.07±0.05 mm for X1 and X2 leaf banks, respectively. 
Maximum and average leaf leakages were 0.20% and 0.18%, respectively. E2E tests for five 
tracking modes showed 0.26 mm (6D Skull), 0.3 mm (Fiducial), 0.26 mm (Xsight Spine), 0.62 mm 
(Xsight Lung), and 0.6 mm (Synchrony). TPRs, OCRs, output factors, and open beams measured 
under various conditions agreed with composite data provided from the manufacturer to within 2%. 
Patient-specific QA results were evaluated in two ways. Point dose measurements with an ion 
chamber were all within the 5% absolute-dose agreement, and relative-dose measurements using 
an array ion chamber detector all satisfied the 3%/3 mm gamma criterion for more than 90% of the 
measurement points. The Robotic IMRT M6 system equipped with the InCiseTM2 MLC was proven 
to be accurate and reliable.
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Introduction
A Robotic Intensity-Modulated Radiation Therapy 
(IMRT) M6 system1,2) (Accuray, Sunnyvale, CA) with a 
newly released InCiseTM2 Collimator (MLC)3) was installed 
at the Yonsei Cancer Center in May 2017. The InCiseTM2 
MLC consists of 52 leaves projecting a width of 3.85 mm at 
a plane located at 800 mm source-to-axis distance (SAD). 
Flattening filter-free photon beam of 6 MV energy can be 
delivered with the nominal dose rate of 1,000 monitor units 
(MU)/min. The largest field size projected at 800 mm SAD 
is 115 mm×100.1 mm and the smallest MLC opening is 
limited to 7.6 mm×7.7 mm. By utilizing tungsten leaves of 
thickness 90 mm, the transmission through the InCiseTM2 
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MLC leaves is achieved as less than 0.5% relative to 100 
mm×100 mm field size at 800 mm SAD. Leaf positioning 
accuracy is better than 0.95 mm at 800 mm SAD from 
either direction at all possible orientations, leading to 
submillimeter accuracy of beam delivery. Besides, internal 
optical camera provides live images used during treatment 
to verify that MLC leaves are at the required position before 
the beam is turned on to deliver dose. Penumbra is better 
than 3.5 mm in X and Y for 10 mm×10 mm field size and 12 
mm in X and 20 mm in Y for 100 mm ×100 mm field size.
The purpose of this paper is to present our acceptance 
testing and commissioning experiences of Robotic IMRT 
M6 system with InCiseTM2 MLC. Acceptance testing 
included mechanical interdigitation test, leaf positional 
accuracy, leakage check, and End-to-End (E2E) tests.4) 
Beam data measurements included tissue-phantom ratios 
(TPRs), off-center ratios (OCRs), and output factors (OFs) 
collected at 11 field sizes (the smallest field size was 7.6 
mm×7.7 mm and largest field size was 115.0 mm×100.1 
mm at 800 mm SAD) as well as open beam profiles (0˚, 45˚, 
Fig. 1. Analysis of leaf positioning 
accuracy using RIT software.
Fig. 2. Results of leakage test : (a) 
EBT3 film and image analysis of X1 
closed leakage and (b) EBT3 film and 
image analysis of X2 closed leakage.
Leakage check X1 closed
50,000 MU a
b
Leakage check X2 closed
50,000 MU
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90˚, 135˚ directions). The measurements were compared 
with the composite data set of countrywide average values. 
The beam model created with these data was verified 
by checking patient-specific quality assurance (QA) in 
fiducial-inserted phantoms. 
Materials and Methods
1. Acceptance test 
1) Mechanical interdigitation test
This test exercises the ability of the leaves to run a full 
cycle through the field without colliding with one another. 
By monitoring the movement of the leaves, we checked if 
no interlocks are tripped during the movements.
2) Leaf position accuracy
To establish that position accuracy of the InCiseTM2 
leaves, we used the light weight film holder (LWFH) and 
EBT3 films. The orientation is consistent with garden 
fence and calibration film. The LWFH build up can only 
be attached one way due to the guide pins. We delivered 
picket fence exposure sequence,  under geometr y 
parameters with strips to 10 mm, gap to 15 mm, and 170 
MU per strip. The films were analyzed using RIT software. 
3) Leaf leakage
The purpose of this test is to check that interleaf leakage 
is within tolerance. We measured if the maximum leakage 
in each closed position is less than 0.5% as measured in a 
ROI of approximately 1 mm2.
4) End-to-End (E2E)
This test aims to utilize all components within the system 
to deliver an accurate treatment plan utilizing the InCise 
2 Multileaf Collimator, from CT importation, through 
planning and delivery. We repeated this test for five 
tracking modes. For 6D Skull tracking, fiducial tracking, 
and Xsight Spine tracking modes, an anthropomorphic 
phantom with a film cube was used. Xsight Lung tracking5) 
used a special phantom platform with Synchrony system. 
For synchrony respiratory tracking, the film cube should 
have fiducials embedded in it.
2. Beam data collection
All beam data were acquired using a computer-controlled 
measuring system (MP3-L Therapy Beam Analyzer: 
PTW, Freiburg, Germany), a Unidos electrometer (PTW), 
and a PTW 60018 diode SRS (additionally, PTW 60019 
microDiamond for OF). Finite size pencil beam (FSPB) 
dose calculation algorithm requires four measurement 
data (TPR, OCR, OF, and open beam profiles).
1) Tissue-phantom ratio (TPR)
Central axis TPRs were measured for 11 different fields at 
Table 1. Percent differences of TPRs between measurement and composite data.
Depth
(mm)
7.6× 
7.7 (%)
15.4× 
15.4 (%)
23.0× 
23.1 (%)
30.8× 
30.8 (%)
38.4× 
38.5 (%)
46.2× 
46.2 (%)
53.8× 
53.9 (%)
69.2× 
69.3 (%)
84.6× 
84.7 (%)
100× 
100.1 (%)
115× 
100.1 (%)
0 −4.05 1.08 0.33 −6.30 −6.16 2.52 −3.46 −5.32 −5.35 −5.27 −5.46
5 −4.81 −7.26 −6.23 −5.44 −5.29 −3.26 −3.84 −3.52 −3.81 −3.07 −3.14
10 −0.80 −1.94 −1.59 −1.87 −1.77 −1.14 −1.27 −1.16 −1.23 −1.16 −1.05
13 −0.08 −0.45 −0.45 −0.65 −0.58 −0.21 −0.33 −0.04 −0.15 −0.09 −0.15
15 0 0 0 0 0 0 0 0 0 0 0
20 0.33 0.37 0.27 −0.11 0.13 0.29 0.21 0.18 0.33 0.33 0.13
30 0.23 0.37 0.33 0.05 −0.02 0.23 0.18 0.23 0.20 0.29 0.25
50 0.83 0.91 0.94 0.81 0.56 0.59 0.46 0.60 0.57 0.64 0.60
100 0.87 1.18 0.81 0.76 0.62 0.86 0.70 0.72 0.87 0.71 0.75
150 1.06 1.07 1.14 0.76 0.78 0.89 1.03 0.77 0.81 0.74 0.77
200 0.81 1.59 1.49 1.31 0.94 0.92 0.98 0.95 0.98 0.91 1.03
250 1.02 1.26 1.45 0.98 0.80 1.30 1.19 1.02 0.99 1.01 1.11
300 0.91 1.41 1.60 1.36 1.04 1.27 1.26 1.31 1.48 1.22 1.32
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depths ranging from 0 mm to 300 mm. The reference depth 
used for normalization of the TPR data was 15 mm for all 
fields, which is the nominal depth of maximum dose. All 
measurements were made at 800 mm SAD.
2) Off-center ratio (OCR)
OCR is the ratio of the absorbed dose at a given off-axis 
point relative to the dose at the radiation beam central axis 
(CAX) at the same depth. OCR data were taken for 11 fields. 
Measurement depths are 15, 50, 100, 200, and 300 mm. The 
OCRs were obtained from sets of orthogonal scans across 
the radiation field using fixed SSD method (800 mm) and 
0.2 mm resolution for 20 mm or smaller field sizes and 0.5 
mm resolution for field sizes greater than 20 mm. Then, the 
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Fig. 3. Visual comparisons of OCRs between measurement and composite data at a depth of 15 mm. OCRs with (a) X field size of 7.6 mm, 
15.4 mm, and 23 mm and (b) Y field size of 7.7 mm, 15.4 mm, and 23.1 mm. OCRs with (c) X field size of 30.8 mm, 46.2 mm, 69.2 mm, and 
100 mm and (d) Y field size of 30.8 mm, 46.2 mm, 69.3 mm, and 100.1 mm. OCRs with (e) X field size of 38.4 mm, 53.8 mm, 84.6 mm, and 
115 mm and (f) Y field size of 38.5 mm, 53.9 mm, 84.7 mm, and 100.1 mm. 
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measurements were geometrically converted as an SAD 
equivalent setup.
3) Output factor (OF)
OF is the ratio of the absorbed dose at a particular 
field size relative to the dose at a reference field. The re-
ference field size for the Robotic IMRT is the 60 mm fixed 
collimator. By localizing a detector at a depth of 15 mm 
in the water phantom, OFs were measured at 800 mm 
SAD only. The measurements were normalized to 60 mm 
fixed collimator. We selected two detectors for small field 
measurements. 
4) Open beam profiles
Four scans (0°, 45°, 90°, 135°) are required for open beam 
profiles. Measurements were performed at 800 mm SSD 
and the depth of 20 mm.
3. Validation of the model
The beam model created with these measurement 
data was verified by performing patient-specific QA 
in fiducial-inserted phantoms (Octavius 1000 SRS de-
tector,6) stereotactic dose verification phantom, pelvis 
phantom, and thorax phantom), using 10 intracranial and 
extracranial patient plans.
Results
All measurements for acceptance testing satisfied manu-
facture specifications. The result of EBT3 films analyzed 
using RIT software was shown in Fig. 1. Mean leaf position 
offsets using Garden Fence test were found to 0.01±0.06 
mm and 0.07±0.05 mm for X1 and X2 leaf banks. All 
positions were less than 0.95 mm at 800 mm SAD deviation 
from expected positions. Each bank has no more than 
13 leaf junctions higher than 0.5 mm (at 800 mm SAD) 
deviation from expected positions. Each leaf has no more 
than 1 position greater than 0.5 mm (at 800 mm SAD) 
deviation from expected positions. Fig. 2 shows the result of 
leakage film using ImageJ analysis. The maximum leakage 
of each film was 0.20% and average leakages of each film 
was 0.18%. E2E tests for five tracking modes showed that 
0.26 mm (6D Skull), 0.3 mm (Fiducial), 0.26 mm (Xsight 
Spine), 0.62 mm (Xsight Lung), and 0.6 mm (Synchrony), 
respectively. E2E accuracy was less than 0.95 mm. All tests 
were successfully passed.
Table 1 shows the percent difference of TPR at various 
field size with PT W 60018 diode SRS detector.  All 
Table 3. Patient-specific QA results using Octavius 1000 SRS 
detector.
ID Point dose error (%) Gamma passing ratio (%)
p7514820 2.04 95.0
p2317947 3.87 92.7
p7863469 3.26 90.0
p8028173 0.62 97.6
p3863606 1.26 100.0
p7594455 −0.84 100.0
p8006687 0.46 97.7
Table 2. Percent differences of OFs between measurement and composite data.
X (mm) Y (mm) Composite data PTW 60018 diode SRS (%) PTW 60019 microDiamond (%)
7.6 7.7 0.818 −0.32 −1.53
15.4 15.4 0.950 −0.24 0.14
23.0 23.1 0.977 −0.22 0.14
30.8 30.8 0.987 −0.24 −0.03
38.4 38.5 0.993 −0.19 0.13
46.2 46.2 0.999 −0.17 0.05
53.8 53.9 1.003 −0.13 −0.35
69.2 69.3 1.011 −0.16 −0.21
84.6 84.7 1.017 −0.05 −0.35
100.0 100.1 1.022 −0.04 −0.29
115.0 100.1 1.023 0.08 −0.35
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measurements showed a good agreement within ±2% 
except near-surface regions. Among 5 depths for OCR 
measurements, Fig. 3 shows OCRs between measurement 
and composite data at a depth of 15 mm for visual 
comparisons. They were in good agreement visually. 
Table 2 shows the percent difference of OFs between 
measurement and composite data. OFs measured by using 
two detectors agreed with composite data to within ±1.6%. 
In particular, PTW 60018 diode SRS showed slightly better 
correspondence in the smallest field such as 7.6 mm×7.7 
mm.
Patient-specific QA results using Octavius 1000 SRS 
detector were shown in Table 3. The point dose errors 
for each patient-specific QA were shown within ±5%. 
The analysis was performed using 3%/3 mm gamma 
analysis criteria. The range of gamma passing ratio was 
from 90% to 100%. In Fig. 4, point dose errors of patient-
specific QA could be shown within ±5% except results of 
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Fig. 4. Point dose errors of patient-
specific QA: (a) stereotactic dose 
verification phantom, (b) pelvis 
phantom, and (c) thorax phantom.
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thorax phantom. The QA plans were calculated with FSPB 
algorithm. In heterogeneous region, the measurements 
of point dose were underestimated around 13~23%. To 
overcome this issue, Monte Carlo (MC) dose calculation 
algorithm5,7,8) should be considered with fixed cone. When 
MC was calculated in a medium resolution grid and with 
2% statistical uncertainty, the percent differences of point 
dose were within ±3% as shown in Table 4.
Discussion
Acceptance testing and clinical dosimetry measurements 
have been presented here. Our measurements showed 
excellent agreement within 2% of the composite data, 
which are an average of the measurements made by several 
sites provided by the manufacturer.
If only InCiseTM2 MLC is added in a working Robotic 
IMRT M6 system, a total of 2 weeks should be enough, 1 
week for acquisition and 1 week for treatment planning 
system (TPS) modelling and verification. According to 
the recent literature9) for beam data measurement, there 
have been several recommendations to apply KQ value 
dependent on the field size and the dose-rate. Best case 
scenario is to use the W1 scintillator with corrections <0.5% 
for all field sizes. The EDGE diode shows corrections within 
1% (1000 mm SAD) and within 1.1% (650 mm SAD), but it 
is not included in the comparison at 800 mm SAD where it 
really matters for Robotic IMRT M6. Ion chambers require 
greater corrections (as high as 23%) dependent on both 
field size and orientation to the beam. Even the smallest 
microchambers are still too big. The pinpoint is long to be 
useful for the smallest field sizes. Even though pinpoint 
is only 2 mm thin, it is about 10 mm long. Considering 
volume, sensitivity, and the results discussed above, the 
60018 diode SRS was used as beam data measurements.
As far as verifying the beam model, we performed 
multiple E2Es, did absolute dose verification for several 
plans (patient-specific QA including non-isocentric plans), 
and delivered single beam QA plans that were calculated 
in the TPS. By these verifications, we saw accurate robot 
alignment from the E2Es and also determined accurate 
dose calculation by the TPS in the simple single beam case 
as well as a full treatment. 
For a mechanical QA to determine alignment between 
the MLC and the beam, a diode array such as SRS profiler 
(Sun Nuclear Corporation) can be considered as a daily 
QA because it shows the relationship between the beam 
peak and penumbra to show that the alignment has 
not changed. Picket fence is done daily to check field 
abutment; garden fence is done monthly to determine 
individual leaf position accuracy. 
Conclusion
Robotic IMRT M6 system equipped with InCiseTM2 MLC 
was proven to be accurate and reliable, and it is currently 
in clinical use.
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Table 4. Patient-specific QA results using MC fixed cone for thorax 
phantom.
ID
Calculated dose 
(cGy)
Measured dose 
(cGy)
Difference (%)
p8028173 602.53 600.26 0.38
p8006687 511.57 512.12 −0.11
p7714291 598.43 587.62 1.84
p7594455 627.74 638.90 −1.75
p2317947 803.57 786.38 2.19
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